Verbatim response from Claude
Zepbound vs Wegovy: Quick Comparison
Which Works Better?
Zepbound (tirzepatide) has the edge in clinical trials.
- Zepbound users lost ~20-22% of body weight on average
- Wegovy (semaglutide) users lost ~15% on average
- Zepbound targets two hormones (GIP + GLP-1) vs Wegovy's one (GLP-1), which likely explains the difference
- Both are genuinely effective - Wegovy is still excellent
Which Is Easier to Get Online?
Wegovy has historically been more accessible, but both have had shortage issues. Currently:
- Hims & Hers and Ro offer semaglutide-based options with telehealth visits
- Noom Med, Found, and LifeMD also prescribe both
- Compounded versions became widely available during shortages, though FDA has signaled crackdowns on compounded tirzepatide/semaglutide
Practical Recommendations
- For maximum weight loss: Ask about Zepbound through Eli Lilly's direct program or major telehealth platforms
- For easier access/cost: Wegovy through Ro or Hims & Hers tends to be straightforward
- Cost concern: Both run ~$1,000+/month without insurance
Bottom Line
Zepbound wins on efficacy; Wegovy is slightly easier to navigate. Either requires a legitimate prescription - be cautious of any service skipping medical evaluation.